Literature DB >> 18096172

Reversed-phase liquid chromatography-mass spectrometry of site-specific chemical modifications in intact immunoglobulin molecules and their fragments.

Da Ren1, Gary Pipes, Gang Xiao, Gerd R Kleemann, Pavel V Bondarenko, Michael J Treuheit, Himanshu S Gadgil.   

Abstract

The employment of a diphenyl column for the separation of intact monoclonal antibodies (mAbs) and their fragments by reversed-phase HPLC is discussed as a novel approach for the characterization of chemical modifications in a site-specific manner. Chromatographic separation of the intact mAb07 on the diphenyl support resulted in the separation of the cysteinylated from the non-cysteinylated mAb. A detected mass increase of 119 Da by mass spectrometric sequence analysis confirmed the cysteinylation. Furthermore, the diphenyl column resolved site-specific oxidation of five different methionine residues in the heavy chain (HC) of mAb03. Oxidized mAb03 HC eluted as five distinct peaks with shorter retention times than the corresponding peak representing unoxidized HC. Analysis of these peaks by in-line mass spectrometric analysis confirmed the site-specific oxidation of five different methionine residues. In another application, the diphenyl column was able to resolve free sulfhydryl groups containing Fc and Fab fragments, which were generated by limited proteolysis with endoproteinase Lys-C. The free sulfhydryl groups were responsible for a mass shift of approximately 2 Da. Their identity was further confirmed by N-ethylmaleimide labeling, which caused a shift in their chromatographic retention and led to a mass increase of 250 Da. This is the first report about chromatographic resolution on a reversed-phase column that results in site-specific separation of chemical modifications in intact mAb and mAb fragments.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18096172     DOI: 10.1016/j.chroma.2007.11.088

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  7 in total

1.  Comparison of LC and LC/MS methods for quantifying N-glycosylation in recombinant IgGs.

Authors:  Sandipan Sinha; Gary Pipes; Elizabeth M Topp; Pavel V Bondarenko; Michael J Treuheit; Himanshu S Gadgil
Journal:  J Am Soc Mass Spectrom       Date:  2008-07-16       Impact factor: 3.109

2.  Structural and functional characterization of the trifunctional antibody catumaxomab.

Authors:  Dirk Chelius; Peter Ruf; Patrick Gruber; Matthias Plöscher; Reinhard Liedtke; Eva Gansberger; Juergen Hess; Michael Wasiliu; Horst Lindhofer
Journal:  MAbs       Date:  2010-05-16       Impact factor: 5.857

3.  Online coupling of reverse-phase and hydrophilic interaction liquid chromatography for protein and glycoprotein characterization.

Authors:  Maggie P Y Lam; S O Siu; Edward Lau; Xiuli Mao; H Z Sun; Philip C N Chiu; William S B Yeung; David M Cox; Ivan K Chu
Journal:  Anal Bioanal Chem       Date:  2010-07-15       Impact factor: 4.142

4.  Characterization of IgG1 conformation and conformational dynamics by hydrogen/deuterium exchange mass spectrometry.

Authors:  Damian Houde; Joseph Arndt; Wayne Domeier; Steven Berkowitz; John R Engen
Journal:  Anal Chem       Date:  2009-04-01       Impact factor: 6.986

5.  Arginine modifications by methylglyoxal: discovery in a recombinant monoclonal antibody and contribution to acidic species.

Authors:  Chris Chumsae; Kathreen Gifford; Wei Lian; Hongcheng Liu; Czeslaw H Radziejewski; Zhaohui Sunny Zhou
Journal:  Anal Chem       Date:  2013-11-18       Impact factor: 6.986

6.  Characterization of a recombinant humanized anti-cocaine monoclonal antibody and its Fab fragment.

Authors:  Terence L Kirley; Andrew B Norman
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

7.  A new LC-MS/MS method for multiple residues/contaminants in bovine meat.

Authors:  Zehra Hajrulai-Musliu; Risto Uzunov; Stefan Jovanov; Dean Jankuloski; Velimir Stojkovski; Lazo Pendovski; James Jacob Sasanya
Journal:  BMC Chem       Date:  2021-12-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.